IO Biotech Inc IOBT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.50quote price arrow down-0.04 (-2.60%)
Volume
20,746
52 week range
0.82 - 2.29
Loading...
  • Open1.56
  • Day High1.57
  • Day Low1.46
  • Prev Close1.54
  • 52 Week High2.29
  • 52 Week High Date05/08/23
  • 52 Week Low0.82
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap98.821M
  • Shares Out65.88M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-20.21

KEY STATS

  • Open1.56
  • Day High1.57
  • Day Low1.46
  • Prev Close1.54
  • 52 Week High2.29
  • 52 Week High Date05/08/23
  • 52 Week Low0.82
  • 52 Week Low Date10/30/23
  • Market Cap98.821M
  • Shares Out65.88M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-20.21

RATIOS/PROFITABILITY

  • EPS (TTM)-2.15
  • P/E (TTM)-0.70
  • Fwd P/E (NTM)-1.08
  • EBITDA (TTM)-91.228M
  • ROE (TTM)-63.29%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IO Biotech Inc

 

Profile

MORE
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO...
Peter Hirth Ph.D.
Chairman of the Board
Mai-Britt Zocca Ph.D.
President, Chief Executive Officer, Founder, Director
Amy Sullivan
Chief Financial Officer
Brian Burkavage
Chief Accounting Officer
Devin Smith
General Counsel
Address
Ole Maaloes Veh 3
Copenhagen
2200
Denmark

Top Peers

SYMBOLLASTCHG%CHG
ANIX
Anixa Biosciences Inc
3.02+0.11+3.78%
PMVP
PMV Pharmaceuticals Inc
2.16-0.02-0.92%
ALLK
Allakos Inc
1.26+0.03+2.86%
OTLK
Outlook Therapeutics Inc
8.00-0.21-2.56%
ELTX
Elicio Therapeutics Inc
9.35+0.30+3.31%